UK equities extended their losing streak on Tuesday, pressured by renewed tariff threats from U.S. President Donald Trump tied to Greenland, while domestic data a ...

Read More »

GSK to acquire RAPT Therapeutics for $2.2 billion

Investing.com -- GSK plc (LON:GSK) announced Tuesday it has entered a definitive agreement to acquire RAPT Therapeutics (NASDAQ:RAPT), a California-based clinical-stage biopharmaceutical company, for ...

Read More »

GSK przejmie RAPT Therapeutics za 2,2 mld

Brian Wong, Prezes i CEO RAPT Therapeutics, powiedział: "Ta transakcja ma potencjał zapewnienia dostępu do globalnych możliwości rozwoju i komercjalizacji, zasobów i infrastruktury, które oferuje GSK, ...

Read More »

FTSE 100 Pauses After Record Close

The FTSE 100 (UKX) hovered near flat on Tuesday, following its record close on Monday. Healthcare stocks weighed on the index, with AstraZeneca (LON:AZN) and GSK (LON:GSK) down around 1%, while BAE ...

Read More »

GSK’s bepirovirsen shows promising results in chronic hepatitis B trials

Investing.com -- GSK plc (LON:GSK) on Wednesday annoucned positive phase III trial results for bepirovirsen, a potential first-in-class treatment for chronic hepatitis B (CHB), meeting primary ...

Read More »